News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Chelsea Therapeutics, Inc. 2Q Loss Narrows on Gain
August 5, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AP -- Chelsea Therapeutics International Ltd., which is developing a drug candidate to treat low blood pressure, said Wednesday its loss narrowed on a gain from prior impairments on auction-rate securities.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Parkinson’s disease
BioVie shares halve on murky Parkinson’s disease readout
August 6, 2026
·
3 min read
·
Gabrielle Masson
IPO
Braveheart pumps more life into biotech IPO market with $382M expected debut
August 6, 2026
·
1 min read
·
Gabrielle Masson
Pipeline
Sanofi pauses mid-stage lung study amid new CEO’s ‘rigorous portfolio prioritization’
August 6, 2026
·
2 min read
·
Tristan Manalac
Venture capital
LifeMine raises $263M in mission to improve organ transplant aftercare
August 6, 2026
·
2 min read
·
Annalee Armstrong
